Thioredoxin Reductase Assay Kit (Colorimetric) (ab83463)
Key features and details
- Assay type: Enzyme activity
- Detection method: Colorimetric
- Platform: Microplate reader
- Assay time: 40 min
- Sample type: Cell culture extracts, Other biological fluids, Tissue Extracts, Urine
Overview
-
Product name
Thioredoxin Reductase Assay Kit (Colorimetric) -
Detection method
Colorimetric -
Sample type
Urine, Cell culture extracts, Other biological fluids, Tissue Extracts -
Assay type
Enzyme activity -
Assay time
0h 40m -
Product overview
Thioredoxin Reductase Assay Kit (ab83463) is a specific assay for detecting Thioredoxin Reductase (TrxR) activity.
In the thioredoxin reductase assay protocol, TrxR catalyzes the reduction of DTNB to TNB2- in the presence of NADPH, which generates a strong yellow color (ODmax = 412 nm).
Other enzymes present in crude biological samples such as glutathione reductase and glutathione peroxidase can also reduce DTNB. In order to measure TrxR-only activity, a TrxR specific inhibitor is used in a separate reaction to determine TrxR specific activity. The difference between total DTNB reduction in the sample and DTNM reduction in the sample in presence of TrxR inhibitor is the value of specific TrxR activity in the sample.
We have tested the GR positive control from ab83461 in the conditions of ab83463, and we do not observe activity of the GR positive control.
Thioredoxin reductase assay protocol summary:
- add samples and standards to wells
- add reaction mix
- analyze with a microplate reader over 20 min -
Notes
This product is manufactured by BioVision, an Abcam company and was previously called K763 Thioredoxin Reductase Activity Colorimetric Assay Kit. K763-100 is the same size as the 100 test size of ab83463.
Thioredoxin reductase (TrxR, EC 1.8.1.9) is a ubiquitous mammalian enzyme that catalyzes the NADPH-dependent reduction of the redox protein thioredoxin, as well as of other endogenous and exogenous compounds such as selenite, lipid hydroperoxides and hydrogen peroxide.
-
Platform
Microplate reader
Properties
-
Storage instructions
Store at -20°C. Please refer to protocols. -
Components Identifier 100 tests DTNB Red 1 vial NADPH Blue 1 vial TNB Standard Brown 1 vial TrxR Assay Buffer WM 1 x 25ml TrxR Inhibitor Clear 1 vial TrxR Positive Control Green 1 vial -
Research areas
-
Relevance
Thioredoxin reductase (TrxR) (EC 1.8.1.9) is a ubiquitous enzyme which is involved in many cellular processes such as cell growth, p53 activity, and protection against oxidation stress, etc. The mammalian TrxR reduces thioredoxins as well as non-disulfide substrates such as selenite, lipoic acids, lipid hydroperoxides, and hydrogen peroxide. -
Cellular localization
TXNRD1: Cytoplasmic. TXNRD2: Cytoplasmic. Nuclear. Microsome. Endoplasmic reticulum. TXNRD3: Mitochondrial. -
Alternative names
- EC 1.8.1.9
- gene associated with retinoic and interferon-induced mortality 12 protein
- Gene associated with retinoic and interferon-induced mortality 12 protein (GRIM-12)
see all
Images
-
Functional Studies - beta Thioredoxin reductase Assay Kit (ab83463)Image from Bulman CA et al., PLoS One. 2015;9(2):e0003534. Fig 4(A).; doi: 10.1371/journal.pntd.0003534. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
Activity of endogenous Brugia thioredoxin reductase from soluble worm lysates following incubation with 1% DMSO or 0.3 μM, 0.1 μM, or 0.03 μM of auranofin in vitro. Percentages indicate the percent activity of TrxR compared to DMSO controls. Thioredoxin reductase activity was significantly reduced (p < 0.05) to 15%, 33% and 69% of endogenous activity, respectively, compared to the activity in DMSO-treated worms.
Thioredoxin reductase activity of worm lysates was assayed using female B. malayi treated in vitro with either 0.3 μM, 0.1 μM, or 0.03 μM auranofin or 1% DMSO. After 5 hours of treatment, worm motility was measured using the Worminator, and then worms (24 in each group) were pooled, washed three times in PBS, and lysed by douncing in a glass homogenizer in assay buffer (ab83463) with 1 mM PMSF. The crude lysates were centrifuged at 10,000 rcf for 15 minutes at 4°C to pellet insoluble material. The total protein concentrations of soluble lysates were measured using the Bradford assay. The soluble lysates were incubated for 20 minutes in assay buffer or assay buffer with a proprietary thioredoxin reductase specific inhibitor before adding a specific substrate, DTNB (5, 5′-dithiobis (2-nitrobenzoic) acid), and measuring activity at 20 second intervals for 40 minutes using the SpectraMax Plus Microplate Reader (Molecular Devices, Sunnyvale, CA) at λ = 412 nm. Lysates were tested in duplicate. TrxR activity was calculated based on the linear amount of TNB produced per minute per mg of total protein and adjusted for background activity from enzymes other than TrxR in the lysates.
-
Thioredoxin reductase measured in mouse tissue lysates showing activity (mU) per mg protein of sample tested
-
Thioredoxin reductase measured in cell lysates showing activity (mU) per 1 mln of cells tested
-
Standard curve (colourimetric) : mean of duplicates (+/-SD) with background readings substracted
-
Thioredoxin reductase Kinetic Data using ab83463.
Datasheets and documents
-
SDS download
-
Datasheet download
References (28)
ab83463 has been referenced in 28 publications.
- Espino M et al. Antioxidant Activities and Selenogene Transcription in the European Sea Bass (Dicentrarchus labrax) Liver Depend, in a Non-linear Manner, on the Se/Hg Molar Ratio of the Feeds. Biol Trace Elem Res 200:2365-2379 (2022). PubMed: 34331176
- Wang HL et al. Regulation of cytokinin biosynthesis using PtRD26pro -IPT module improves drought tolerance through PtARR10-PtYUC4/5-mediated reactive oxygen species removal in Populus. J Integr Plant Biol 64:771-786 (2022). PubMed: 34990062
- Song MY et al. Energy restriction induced SIRT6 inhibits microglia activation and promotes angiogenesis in cerebral ischemia via transcriptional inhibition of TXNIP. Cell Death Dis 13:449 (2022). PubMed: 35562171
- Abdelwahab EMM et al. Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited. Apoptosis 26:253-260 (2021). PubMed: 33860865
- Lippmann J et al. Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma. Transl Oncol 13:100785 (2020). PubMed: 32416440